Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Allogene Therapeutics Inc shares valued at $19,916 were sold by MESSEMER DEBORAH M. on Dec 09 ’24. At $2.18 per share, MESSEMER DEBORAH M. sold 9,136 shares. The insider’s holdings dropped to 157,629 shares worth approximately $0.3 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Humer Franz B sold 9,221 shares, netting a total of over 19,917 in proceeds. Following the sale of shares at $2.16 each, the insider now holds 307,507 shares.
Before that, MESSEMER DEBORAH M. had added 9,136 shares to its account. In a trade valued at $19,954, the Director bought Allogene Therapeutics Inc shares for $2.18 each.
Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in late May. As of January 05, 2024, JMP Securities has decreased its “Mkt outperform” rating to a “Mkt perform” for ALLO. Earlier on January 05, 2024, Guggenheim downgraded its rating. Their new recommendation was “a Neutral” for ALLO stock which previously was a “a Buy”.
Analyzing ALLO Stock Performance
During the last five days, there has been a drop of approximately -10.98%. Over the course of the year, Allogene Therapeutics Inc shares have dropped approximately -40.65%. Shares of the company reached a 52-week high of $5.78 on 03/08/24 and a 52-week low of $1.83 on 12/13/24. A 50-day SMA is recorded $2.51, while a 200-day SMA reached $2.89. Nevertheless, trading volume fell to 2.76 million shares from 2.21 million shares the previous day.
Support And Resistance Levels for Allogene Therapeutics Inc (ALLO)
According to the 24-hour chart, there is a support level at 1.80, which, if violated, would cause prices to drop to 1.70. In the upper region, resistance lies at 2.06. The next price resistance is at 2.22. RSI (Relative Strength Index) is 36.48 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.17, which suggests the price will decrease in the coming days. Percent R is at 90.12%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
